Palbociclib Side Effects
Like other anticancer medicines, Palbociclib can cause side effects.
Some reactions are relatively common and manageable, while others can be serious and require urgent medical attention.
Not every patient experiences the same side effects.
The likelihood and severity of adverse reactions can depend on factors such as:
- The treatment combination
- Dose strength
- Duration of treatment
- Individual health status
- Other medicines
- Laboratory findings
Patients should discuss potential risks with their oncology team before starting treatment.
Neutropenia
One of the most important adverse reactions associated with Palbociclib is neutropenia.
Neutrophils are white blood cells that help protect the body against infection.
When neutrophil levels become low, the patient may be more vulnerable to certain infections.
This is why regular complete blood counts are an important part of Palbociclib treatment.
A low neutrophil count may not always cause obvious symptoms.
However, infection can become serious.
Patients should contact their healthcare team promptly if they develop symptoms such as fever, chills or other signs of infection.
Leukopenia
Palbociclib can also reduce the overall number of white blood cells, a condition known as leukopenia.
White blood cells play important roles in immune function.
Laboratory monitoring helps healthcare professionals identify clinically significant changes.
Anemia
Some patients may experience anemia or reductions in red blood-cell counts.
Possible symptoms can include:
- Fatigue
- Weakness
- Reduced exercise tolerance
- Shortness of breath
However, these symptoms can also result from cancer or other medical conditions.
Appropriate medical evaluation is required.
Thrombocytopenia
Palbociclib can affect platelet counts.
Platelets are involved in normal blood clotting.
A clinically significant reduction in platelets may increase concerns about bleeding or bruising.
Patients should report unusual bleeding or bruising to their healthcare provider.
Fatigue
Fatigue is a commonly reported problem during cancer treatment.
Fatigue can range from mild tiredness to significant exhaustion.
Possible contributing factors include:
- The cancer itself
- Palbociclib
- Endocrine therapy
- Anemia
- Sleep problems
- Emotional stress
- Infection
- Other medical conditions
Persistent or severe fatigue should be discussed with the healthcare team.
Gastrointestinal symptoms
Some patients may experience gastrointestinal symptoms during treatment.
These can include:
- Nausea
- Diarrhea
- Vomiting
- Decreased appetite
Persistent or severe symptoms may require medical attention because dehydration and nutritional problems can develop.
Hair thinning and alopecia
Hair thinning or hair loss can occur during Palbociclib treatment.
The pattern and severity may differ between patients.
Patients concerned about changes in hair should discuss supportive-care options with their healthcare team.
Stomatitis
Some patients may experience mouth-related symptoms, including irritation or inflammation.
Maintaining appropriate oral hygiene and reporting painful or persistent mouth symptoms can help the healthcare team determine whether supportive treatment is needed.
Infections
Because Palbociclib can reduce white blood-cell counts, infections are an important concern.
Symptoms of infection may include:
- Fever
- Chills
- Sore throat
- Cough
- Burning during urination
- New localized pain
- Other unusual symptoms
Patients should follow the specific instructions provided by their oncology team regarding when to seek urgent medical care.
Interstitial lung disease and pneumonitis
Serious respiratory complications, including interstitial lung disease and pneumonitis, have been associated with CDK4/6 inhibitor treatment.
Patients should seek prompt medical evaluation for new or worsening respiratory symptoms such as:
- Shortness of breath
- Difficulty breathing
- Persistent or worsening cough
- Other unexplained respiratory symptoms
These symptoms can have many possible causes, including infection and cancer progression, so medical evaluation is essential.
Side-effect management
Healthcare professionals may manage adverse reactions through strategies such as:
- Laboratory monitoring
- Temporary treatment interruption
- Dose modification
- Supportive treatment
- Treatment of infections or other complications
- Permanent discontinuation in certain serious situations
Patients should not change their treatment independently.
When to seek urgent help
Urgent medical attention may be required for serious symptoms.
Patients should follow local emergency procedures and instructions from their healthcare team.
Potentially serious symptoms can include:
- Fever or suspected infection
- Severe difficulty breathing
- Severe allergic symptoms
- Significant bleeding
- Severe weakness
- Persistent vomiting
- Sudden major deterioration in health
This list is not complete.
Reporting side effects
Patients should tell their healthcare team about all adverse reactions, even symptoms that appear mild.
Early communication may help clinicians identify problems before they become more serious.
Patients may also be able to report adverse reactions through national medicine-safety reporting systems, depending on their country.